Vericel Corporation - Common Stock (NQ:VCEL)

40.26 -2.65 (-6.18%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Earnings Preview For Vericel ↗

November 06, 2024

Via Benzinga

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

October 24, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

August 29, 2024

From Vericel Corporation

Via GlobeNewswire

The Analyst Verdict: Vericel In The Eyes Of 7 Experts ↗

August 27, 2024

Via Benzinga

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

August 26, 2024

From Vericel Corporation

Via GlobeNewswire

Expert Ratings For Vericel ↗

August 09, 2024

Via Benzinga

The Latest Analyst Ratings For Vericel ↗

August 02, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts ↗

July 16, 2024

Via Benzinga

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

August 15, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

August 07, 2024

From Vericel Corporation

Via GlobeNewswire

Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 02, 2024

Via Benzinga

Vericel Reports Second Quarter 2024 Financial Results

August 01, 2024

From Vericel Corporation

Via GlobeNewswire

Critical Insights From Vericel Analyst Ratings: What You Need To Know ↗

May 09, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Vericel ↗

March 26, 2024

Via Benzinga

A Closer Look at 4 Analyst Recommendations For Vericel ↗

March 01, 2024

Via Benzinga

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

July 22, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

July 18, 2024

From Vericel Corporation

Via GlobeNewswire

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

The 3 Highest-Rated Medical Stocks You Can Buy Today ↗

June 27, 2024

Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.

Via InvestorPlace

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

June 11, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 22, 2024

From Vericel Corporation

Via GlobeNewswire

VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

VCEL stock results show that Vericel beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

May 08, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

April 24, 2024

From Vericel Corporation

Via GlobeNewswire

It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗

March 11, 2024

Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.

Via Talk Markets

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

February 29, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

February 27, 2024

From Vericel Corporation

Via GlobeNewswire

3 Top Pharma Stocks for Investors Betting on a Biotech Boom ↗

February 26, 2024

Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.

Via InvestorPlace

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

February 15, 2024

From Vericel Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.